birdseye - on my reading of the orphan drug regime Ovarian cancer therapeutics do qualify as while the INCIDENCE is at the high end of the range, the PREVALENCE is comfortably within the parameters due to relatively short life expectancy.
There is a clear precedent for ovarian cancer treatments being given Orphan status.
CVac will get this designation, no worries.
birdseye - on my reading of the orphan drug regime Ovarian...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.015(4.84%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 28.0¢ | $1.295M | 4.351M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 241309 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 13587 | 6 |
View Market Depth
| Last trade - 12.48pm 02/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |